Salarius Pharmaceuticals, Inc. 8-K

What Happened

• Salarius Pharmaceuticals, Inc. filed a Certificate of Amendment with the Delaware Secretary of State and announced on January 7, 2026 that it is changing its legal name to Decoy Therapeutics Inc., effective January 8, 2026. The Board also approved an amended and restated set of bylaws reflecting the new name. No stockholder vote was required and the name change does not affect stockholder rights.

Key Details

• Name change effective: January 8, 2026.
• Ticker change: common stock expected to move from "SLRX" to "DCOY" on the Nasdaq Capital Market, effective January 8, 2026.
• New website: decoytx.com to go live effective January 8, 2026 with investor relations materials.
• Company issued a press release announcing the changes on January 7, 2026.

Why It Matters

• For investors, this is a corporate rebranding and administrative change: your shares and their rights are unchanged, but the company will trade under a new name and ticker (DCOY) beginning January 8, 2026. Update watchlists, brokerage references, and any saved links to avoid confusion when trading resumes under the new ticker. The filing does not disclose any operational, financial or leadership changes.